Minimal Unit Pricing Study (MUP)
Start date:Febuary 2018 End date:
March 2019 Co-ordinated by:
Miranda Odam Main trial site:
RIE
The Scottish Parliament passed legislation in 2012, known as the Alcohol (Minimum Pricing) (Scotland) Act 2012, which allowed the introduction of a system of Minimum Unit Pricing for alcohol.
Minimum unit pricing sets a ‘floor price’ for a unit of alcohol, now 50p per unit as of 1st May 2018, meaning it can’t be sold for lower than that. The aim of the MUP legislation, according to the Scottish Government, is to reduce the effects of harmful alcohol consumption, and improve the health and wellbeing of Scotland’s population.
We are conducting a study, funded by the NIHR and led by the University of Glasgow, to measure the effect of minimum unit pricing in emergency care settings.
For further information on minimum unit pricing,
For further information on this study please refer to the University of Glasgow website
Chief Investigator
Michele Open
Consultant Emergency Medicine
Research Team
Dr Adam Lloyd
Honorary Research Fellow & Lecturer
Alison Williams
Senior Research Nurse
Allan MacRaild
Stroke Lead Research Nurse
Julia Grahamslaw
Lead Research Nurse
Rachel O'Brien
Lead Research Nurse
Caroline Blackstock
AMU Senior Research Nurse
Rachel O'Brien
Lead Research Nurse
Polly Black
Senior Research Nurse
Liz Hasseld
RRG Research Assistant
Emma Moatt
Research Project Manager
Miranda Odam
Research Nurse Manager
More EMERGE Trials
ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study
ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)
The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.
The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.
This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.
Participants will be asked to return for 6 visits across 12 months to evaluate their health.
Across the UK the trial aims to recruit 10,260 volunteers.
If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh
COV_002 Vaccine Trial
The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.